AMGEN INC's Net Worth

$38.8 Billion

Estimate Recalculated Feb 16, 2024 04:32PM EST

Who is AMGEN INC?

AMGEN INC has an estimated net worth of $38.8 Billion. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., BeiGene, Ltd., Kezar Life Sciences, Inc., Unilife Corp, TETRALOGIC PHARMACEUTICALS Corp, Epizyme, Inc., MICROMET, INC., TULARIK INC, and Neumora Therapeutics, Inc..

SEC CIK

AMGEN INC's CIK is 0000318154

Past Insider Trading and Trends

2020 was AMGEN INC's most active year for acquiring shares with 11 total transactions. AMGEN INC's most active month to acquire stocks was the month of November. 2013 was AMGEN INC's most active year for disposing of shares, totalling 6 transactions. AMGEN INC's most active month to dispose stocks was the month of November. 2020 saw AMGEN INC paying a total of $568,202,059.07 for 30,220,040 shares, this is the most they've acquired in one year. In 2023 AMGEN INC cashed out on 33,603,948 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.21M
3.21M
Jan 11
Form 3
0
0
No matching records found

BeiGene, Ltd. (BGNE) Snapshot price: $153.58

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.88%
165.53K
$302.06
$49,999,938.03
18.94M
Sep 10
Form 4
+0.14%
25.76K
$260.95
$6,722,503.73
18.78M
Scheduled
Dec 18
Form 4
+1.23%
228.14K
$249.61
$56,945,685.69
18.75M
Scheduled
Dec 15 - Dec 17
Form 4
+0.32%
59.39K
$248.49
$14,757,577.60
18.52M
Scheduled
Aug 25
Form 4
+0.67%
123.57K
$234.47
$28,971,917.93
18.46M
Scheduled
Aug 21 - Aug 24
Form 4
+0.93%
168.35K
$233.81
$39,361,622.88
18.34M
Scheduled
Aug 18 - Aug 20
Form 4
+14.33%
29.61M
$14.23
$421,442,751.23
236.25M
Jul 15
Form 3
0
0
No matching records found

Kezar Life Sciences, Inc. (KZR) Snapshot price: $0.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.12M
1.12M
Jun 25
Form 3
0
0
No matching records found

Unilife Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

TETRALOGIC PHARMACEUTICALS Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
990.17K
$7.00
$1,912,298.91
990.17K
Dec 17
Form 3
0
0
No matching records found